According to the latest financial report of Delta-Fly Pharma, the latest earnings per share (TTM) for the company is -56.69. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Delta-Fly Pharma's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Delta-Fly Pharma shows that the company's current ratio is 3.49, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Delta-Fly Pharma, the quick ratio is 3.16, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Delta-Fly Pharma? The latest ROE figure is -31.25%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Delta-Fly Pharma, the total asset return on investment (ROA) is -28.05%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Delta-Fly Pharma's latest financial report to see how their gross margin is doing - currently at --.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Delta-Fly Pharma, the net profit margin is -64.89%, which is a good sign for its profitability.